Evidence map›Paper›PMID 40426710›Full record

ArticleChildren (Basel, Switzerland)2025

Oral Implications of Herbst Device Modification: A Case Report.

Monica Macrì, Mariastella Di Carmine, Antonio Scarano, Felice Festa

Abstract readCase Reports
In one paragraph

Article in Children (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Monica MacrìDepartment of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" of ChietiPescara, 66100 Chieti, Italy.ORCID 0000-0002-1068-1319
Mariastella Di CarmineDepartment of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" of ChietiPescara, 66100 Chieti, Italy.
Antonio ScaranoDepartment of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" of ChietiPescara, 66100 Chieti, Italy.
Felice FestaDepartment of Innovative Technologies in Medicine & Dentistry, University "G. d'Annunzio" of ChietiPescara, 66100 Chieti, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany studies analyse the effectiveness of the Herbst device in the treatment of dentoskeletal Class II malocclusion due to mandibular retrusion. This fixed device was devised by Emil Herbst for Class II treatment using a bite jumping, i.e., a device that holds the jaw in a forced anterior position. Comparison of the results obtained in numerous studies is difficult because they are often not comparable and not congruent due to a number of variables that prevent standardization.

methodsThe purpose of the present study is to report some clinical-level considerations that may be important in order to obtain more predictable therapeutic outcomes. The simplified design of the Herbst device offers better patient comfort and easier cleanability but may show some disadvantages, such as less anchorage.

resultsThe device was evaluated in conjunction with the multi-bracket phase that preceded Herbst therapy and concluded after the device was removed. The therapy was performed in the absence of skeletal anchorage.

conclusionsIn our opinion, standardization of therapy according to precise protocols may positively affect the therapeutic outcomes by achieving faster occlusal stabilization, more proper neuro-muscular balance, less stress on anchor units, and shorter treatment time.

Indexed as

anterior mandibular repositioningcomplicationsdevice managementHerbstmusculoskeletal structures adaptation

Identifiers

PMID40426710
PMCPMC12110008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.